OUTCOMES OF USING FLIXOTIDE FOR PROPHYLACTIC TREATMENT OF ASTHMA IN CHILDREN UNDER 5 YEARS AT THE HANOI MEDICAL UNIVERSITY HOSPITAL

Thị Thảo Lê, Thị Diệu Thúy Nguyễn, Thị Quỳnh Anh Phí

Main Article Content

Abstract

Objective: To evaluate the effectiveness of Flixotide in the prophylactic treatment of asthma in children under 5 years of age at the Hanoi Medical University Hospital. Subjects: 69 children under 5 years old diagnosed with asthma which were using Flixotide for  prophylactic treatment at the Pediatric Department of Hanoi Medical University Hospital between July 2024 and June 2025. Methods: A pre–post descriptive comparative study was conducted at three time points: before treatment, after 1 month and after 3 months of treatment. Results: After 1 month of treatment, the daytime and nighttime symptoms of asthmatic children decreased from 98.6% to 43.5% and from 86.5% to 40.6%, respectively. After 3 months of Flixotide use, these rates further declined to 13.0% and 2.9%. In addition, the proportion of patients with asthma grade 2 decreased from 76.8% before treatment to 8.2%, and asthma grade 3 from 15.9% to 0% after 3 months. After 1 month of treatment, 49.3% of patients had partially controlled asthma, and by 3 months, no patients remained in the uncontrolled asthma. Conclusion: Flixotide is effective in the prophylactic treatment of asthma in children under 5 years of age.

Article Details

References

Global, regional, and national burden of asthma and atopic dermatitis, 1990-2021, and projections to 2050: a systematic analysis of the Global Burden of Disease Study 2021. The Lancet Respiratory medicine. 2025;13(5):425-446.
2. Bộ Y Tế. Hướng dẫn chẩn đoán và điều trị hen trẻ em dưới 5 tuổi. 2016.
3. Đậu Thị Hội. Hiệu quả của Fluticasone propionate trong điều trị dự phòng hen phế quản ở trẻ trên 5 tuổi tại bệnh viện Nhi Trung ương. Luận văn Thạc sỹ Y học. Đại học Y Hà Nội 2019
4. Pagtakhan RD, Bjelland JC, Landau LI, et al. Sex differences in growth patterns of the airways and lung parenchyma in children. Journal of applied physiology: respiratory, environmental and exercise physiology. 1984;56(5):1204-1210
5. Roorda RJ, Mezei G, Bisgaard H, Maden C. Response of preschool children with asthma symptoms to fluticasone propionate. The Journal of allergy and clinical immunology. 2001;108(4):540-546.
6. Pedersen S, Engelstätter R, Weber HJ, et al. Efficacy and safety of ciclesonide once daily and fluticasone propionate twice daily in children with asthma. Pulmonary pharmacology & therapeutics. 2009;22(3):214-220.
7. Lê Thị Thu Hương. Nghiên cứu biến đổi một số tế bào viêm và cytokine trong máu ngoại vi ở trẻ hen phế quản. Luận án Tiến sỹ. Đại học Y Hà Nội 2017
8. Bateman ED, Busse W, Pedersen SE, et al. Global Initiative for Asthma 2016-derived asthma control with fluticasone propionate and salmeterol: A Gaining Optimal Asthma Control (GOAL) study reanalysis. Annals of allergy, asthma & immunology: official publication of the American College of Allergy, Asthma, & Immunology. 2019;123(1):57-63.e52.